Clete Anthony Kushida, MD
Sleep Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kushida’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A50560 · Current
Licensed to practise in California · since 1992 · expires 2028-02-29 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$37,115
Medicare paid this office $37,115 for 300 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 71 | $10,461 | $147 |
| Return visit (30+ min) | 103 | $9,309 | $89 |
| Sleep study in sleep lab (6 years or older) | 69 | $7,233 | $105 |
| Long return visit (40+ min) | 39 | $5,396 | $125 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 22 | $2,498 | $109 |
See all 6 services
| New patient visit (60+ min) | 71 | $10,461 | $147 |
| Return visit (30+ min) | 103 | $9,309 | $89 |
| Sleep study in sleep lab (6 years or older) | 69 | $7,233 | $105 |
| Long return visit (40+ min) | 39 | $5,396 | $125 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 22 | $2,498 | $109 |
| Sleep study including heart rate, breathing, and sleep time | 38 | $1,327 | $35 |
Who their Medicare patients are
300 Original Medicare patients in 2024. Average age 71 · Under 65 11% · 85 and older 8% · Women 47% · Also on Medicaid 18% · Health risk score 1.17. At or below the middle of the specialty; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 67% · Coronary heart disease 28% · Diabetes 24% · Atrial fibrillation 21% · Depression 21% · Chronic kidney disease 20% · Heart failure 15% · Cancer 13% · COPD 9% · Stroke 8% · Dementia 5%.
The office billed $257,671, Medicare allowed $49,997 and paid $37,115; for 362 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 300 | 362 | 71 | 1.17 | $257,671 | $37,115 |
| 2023 | 218 | 272 | 70 | 1.20 | $173,699 | $29,916 |
| 2022 | 134 | 160 | 71 | 1.23 | $103,052 | $17,062 |
| 2021 | 171 | 214 | 72 | 1.20 | $133,851 | $23,718 |
| 2020 | 172 | 291 | 72 | 1.19 | $149,249 | $22,317 |
| 2019 | 192 | 218 | 71 | 1.23 | $91,655 | $20,567 |
| 2018 | 180 | 201 | 72 | 1.14 | $88,954 | $18,140 |
| 2017 | 168 | 202 | 70 | 1.13 | $94,820 | $17,782 |
| 2016 | 212 | 249 | 71 | 1.10 | $103,917 | $22,097 |
| 2015 | 178 | 202 | 70 | 1.24 | $78,699 | $15,918 |
| 2014 | 206 | 252 | 70 | 1.10 | $93,320 | $22,019 |
| 2013 | 207 | 239 | 69 | 1.24 | $63,767 | $13,664 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 75 | $10,080 | $120 |
| New patient visit (60+ min) | 62 | $8,496 | $137 |
| Sleep study in sleep lab (6 years or older) | 39 | $4,184 | $107 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,784 | $111 |
| Return visit (30+ min) | 24 | $2,077 | $87 |
| New patient visit (45+ min) | 11 | $1,366 | $124 |
| Sleep study including heart rate, breathing, and sleep time | 26 | $901 | $35 |
2022: 6 services
| Long return visit (40+ min) | 55 | $7,459 | $124 |
| New patient visit (60+ min) | 22 | $3,213 | $146 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $2,252 | $113 |
| Sleep study in sleep lab (6 years or older) | 19 | $2,056 | $108 |
| Return visit (30+ min) | 12 | $931 | $78 |
| Sleep study including heart rate, breathing, and sleep time | 22 | $808 | $35 |
2021: 5 services
| New patient visit (60+ min) | 46 | $7,359 | $160 |
| Long return visit (40+ min) | 49 | $6,397 | $128 |
| Return visit (30+ min) | 35 | $2,670 | $76 |
| Sleep study in sleep lab (6 years or older) | 17 | $1,768 | $104 |
| Sleep study including heart rate, breathing, and sleep time | 16 | $532 | $33 |
2020: 5 services
| Extended patient service without direct patient contact, first hour | 76 | $7,622 | $100 |
| Sleep study in sleep lab (6 years or older) | 28 | $3,069 | $110 |
| New patient visit (15+ min) | 40 | $1,837 | $46 |
| Return visit (30+ min) | 29 | $1,430 | $49 |
| Short return visit | 25 | $618 | $25 |
2019: 6 services
| Return visit (30+ min) | 95 | $6,585 | $67 |
| New patient visit (60+ min) | 39 | $5,100 | $131 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,726 | $109 |
| New patient visit (60+ min) | 19 | $2,591 | $136 |
| Sleep study in sleep lab (6 years or older) | 20 | $2,206 | $110 |
| Long return visit (40+ min) | 11 | $1,089 | $91 |
2018: 4 services
| New patient visit (60+ min) | 46 | $5,852 | $127 |
| Return visit (30+ min) | 78 | $4,994 | $61 |
| Sleep study in sleep lab (6 years or older) | 25 | $2,599 | $104 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,925 | $113 |
2017: 6 services
| New patient visit (60+ min) | 50 | $5,863 | $117 |
| Return visit (30+ min) | 63 | $4,561 | $66 |
| Sleep study in sleep lab (6 years or older) | 33 | $3,529 | $107 |
| Long return visit (40+ min) | 17 | $1,850 | $92 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,107 | $101 |
| Sleep study including heart rate, breathing, airflow, and effort | 12 | $607 | $51 |
2016: 5 services
| Return visit (30+ min) | 96 | $6,931 | $64 |
| New patient visit (60+ min) | 48 | $6,578 | $137 |
| Long return visit (40+ min) | 32 | $3,140 | $92 |
| Sleep study in sleep lab (6 years or older) | 29 | $3,133 | $108 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,939 | $114 |
2015: 5 services
| Return visit (30+ min) | 85 | $5,453 | $61 |
| New patient visit (60+ min) | 28 | $3,570 | $127 |
| Long return visit (40+ min) | 25 | $2,233 | $86 |
| Sleep study in sleep lab (6 years or older) | 19 | $1,974 | $104 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,251 | $104 |
2014: 6 services
| Return visit (30+ min) | 108 | $7,893 | $66 |
| New patient visit (60+ min) | 35 | $5,223 | $149 |
| Long return visit (40+ min) | 31 | $3,356 | $96 |
| New patient visit (45+ min) | 20 | $2,073 | $104 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $1,696 | $113 |
| Sleep study in sleep lab (6 years or older) | 12 | $1,258 | $105 |
2013: 5 services
| Short return visit (20+ min) | 102 | $4,753 | $41 |
| Return visit (30+ min) | 37 | $2,445 | $64 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,999 | $111 |
| New patient visit (30+ min) | 38 | $1,983 | $52 |
| Sleep study in sleep lab (6 years or older) | 13 | $1,234 | $95 |
Medicaid work
$5,549 in 2024
Medicaid paid $5,549 for 75 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 75 | $5,549 |
| 2024 | 75 | 1 | 24 | $5,549 |
| 2023 | 227 | 2 | 24 | $9,243 |
| 2022 | 166 | 1 | 24 | $8,178 |
| 2021 | 188 | 1 | 25 | $9,184 |
| 2020 | 17 | 1 | 17 | $754 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 159 | $5,965 |
| Long return visit (40+ min) | 68 | $3,277 |
2022
| Return visit (30+ min) | 166 | $8,178 |
2021
| Return visit (30+ min) | 188 | $9,184 |
2020
| Return visit (30+ min) | 17 | $754 |
Money from drug and device companies
$1,908 in 2025
| 2025 | 1 | 4 | $1,908 | $1,908 |
| 2024 | 5 | 28 | $21,180 | $23,649 |
| 2023 | 1 | 1 | $563 | $563 |
| 2022 | 2 | 2 | $5,130 | $5,255 |
| 2021 | 2 | 2 | $5,570 | $5,570 |
| 2020 | 2 | 3 | $4,750 | $4,750 |
| 2019 | 2 | 16 | $12,870 | $16,268 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Avadel CNS Pharmaceuticals | Lumryz | $1,908 | 4 payments
|
See all 4 published payments
| Avadel CNS Pharmaceuticals | Consulting · 2025-07-29 | Lumryz | $545 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-06-24 | Lumryz | $545 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-03-18 | Lumryz | $545 |
| Avadel CNS Pharmaceuticals | Consulting · 2025-02-25 | Lumryz | $273 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $23,649
| Alkermes | None | $12,381 | 13 payments
|
| Eli Lilly and | Mounjaro | $9,915 | 8 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $1,174 | 4 payments
|
| Jazz Pharmaceuticals | Xywav | $143 | 2 payments
|
| Lilly USA | Zepbound | $35 | 1 payment
|
2023: $563
| Avadel CNS Pharmaceuticals | Lumryz | $563 | 1 payment
|
2022: $5,255
| Eisai | Dayvigo | $5,130 | 1 payment
|
| KLS-Martin L.P. | None | $125 | 1 payment
|
2021: $5,570
| Itamar Medical | Watchpat | $3,000 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $2,570 | 1 payment
|
2020: $4,750
| Avadel CNS Pharmaceuticals | None | $4,000 | 2 payments
|
| Merck Sharp & Dohme | None | $750 | 1 payment
|
2019: $16,268
| Merck Sharp & Dohme | Mk-7264 | $11,922 | 14 payments
|
| Genentech | Xolair | $4,346 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Eisai Inc. · Lemborexant Effects on Morning-After Neurocognition Study (Le Mans) · 2022 | Their institution | $95,711 |
| Philips Electronics North America Corporation · St-Gra-16050-Shampap-Shbh · 2019 | Their institution | $20,000 |
| Merck Sharp & Dohme Corporation · A Randomized Double Blind Clinical Trial To Evaluate the Effects of Mk-7264 in Participants With Obstructive Sleep Apnea · 2019 | Their institution | $13,457 |
| Inspire Medical Systems, Inc. · Adhere Registry · 2019 | Their institution | $11,990 |
| EISAI INC. · Lemborexant Effects on Morning-After Neurocognition Study (Le Mans) · 2022 | Their institution | $11,612 |
| Eisai Inc. · Lemborexant Effects on Morning-After Neurocognition Study (Le Mans) · 2024 | Their institution | $6,736 |
| Inspire Medical Systems, Inc. · Adh-Adhere Registry · 2024 | Their institution | $4,032 |
| Inspire Medical Systems, Inc. · Adhere Registry · 2020 | Their institution | $3,776 |
| Inspire Medical Systems, Inc. · Adh-Adhere Registry · 2023 | Their institution | $3,456 |
| Eisai Inc. · Lemborexant Effects on Morning-After Neurocognition Study (Le Mans) · 2023 | Their institution | $1,492 |
| Inspire Medical Systems, Inc. · Adh-Adhere Registry · 2022 | Their institution | $1,152 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780741652
- Licence
- CA A50560California A50560: Current · expires 2028-02-29
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084S0012X (2084S0012X)
- Mailing address
- 300 Pasteur Dr Ste 3301, Stanford, CA, 94305
- NPI first listed
- 2007-01-02
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Quarry Rd, Palo Alto, CA, 94304